Figure 2. Association of Provider Specialty with Ischemic Stroke and Bleeding in Patients with Nonvalvular Atrial Fibrillation by Sociodemographic Factors, 2009–2014 (N=223,891).
* Results of multivariable Cox regression analysis adjusted for age, sex, race, education, heart failure, hypertension, diabetes, stroke, myocardial infarction, kidney disease, liver disease, bleeding history, alcohol use, antiplatelet agents, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, calcium channel blockers, diuretics, amiodarone, digoxin, CHA2DS2-VASc, and HAS-BLED.
CHA2DS2-VASc=congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke/transient ischemic attack, vascular disease, age 65–75 years, and sex category; CI=confidence interval; DOAC=direct oral anticoagulant; HAS-BLED=hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly (age >65 years), drugs/alcohol concomitantly; HR=hazard ratio.